Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis

A major challenge for successful immunotherapy against glioma is the identification and characterization of validated targets. We have taken a bioinformatics approach towards understanding the biological context of IL-13 receptor α2 (IL13Rα2) expression in brain tumors, and its functional significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Christine E., Warden, Charles D., Starr, Renate, Deng, Xutao, Badie, Behnam, Yuan, Yate-Ching, Forman, Stephen J., Barish, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800130/
https://www.ncbi.nlm.nih.gov/pubmed/24204956
http://dx.doi.org/10.1371/journal.pone.0077769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800130/
https://www.ncbi.nlm.nih.gov/pubmed/24204956
http://dx.doi.org/10.1371/journal.pone.0077769

Ejemplares similares